# Dexmedetomidine Added to Ropivacaine Single Shot vs Continuous Interscalene Nerve Block

> **NCT05775861** · NA · UNKNOWN · sponsor: **Ciusss de L'Est de l'Île de Montréal** · enrollment: 96 (estimated)

## Conditions studied

- Anesthesia
- Shoulder Pain
- Post Operative Pain

## Interventions

- **DRUG:** single shot interscalene brachial plexus block group with dexmedetomidine added to ropivacaine group
- **DRUG:** continuous interscalene brachial plexus block

## Key facts

- **NCT ID:** NCT05775861
- **Lead sponsor:** Ciusss de L'Est de l'Île de Montréal
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-23
- **Primary completion:** 2025-01
- **Final completion:** 2025-06
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05775861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05775861, "Dexmedetomidine Added to Ropivacaine Single Shot vs Continuous Interscalene Nerve Block". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05775861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*